Potency of Indonesia Bioresources as Nanomaterials for Health and ...
Transcript of Potency of Indonesia Bioresources as Nanomaterials for Health and ...
DR. ETIK MARDLIYATI, M.ENG
1) Centre for Pharmaceutical and Medical Technology
Agency for the Assessment and Application of Technology (BPPT)
2) Head Division of Pharmaceutics and Health, Indonesia Society for Nano (MNI)
Commercialization of Nanotechnologies
generated by R&D Institutes in Indonesia
Presented at National Workshop on Strengthening R&D Management Capacity of Researchers and Research Managers of R&D Institutes in the Area of Nanotechnology, Jakarta, 27 Juni 2013
1. Bioresources Significance of Indonesia
INDONESIA
Indonesia is blessed with abundance of natural resources
including its biodiversities (the 2nd greatest after Brazil)
Country Diversity value
Endemic value
Total value
Brazil 3.0 1.8 4.8
Indonesia 1.8 2.2 4.0
Columbia 2.6 1.0 3.6
Australia 0.5 1.6 2.1
Mexico 0.8 0.7 1.5
Madagaskar 0.2 1.2 1.4
Peru 0.9 0.3 1.2
China 0.7 0.2 0.9
Philippine 0 0.8 0.8
India 0.4 0.4 0.8
Ecuador 0.5 0 0.5
Venezuela 0.3 0 0.3
Source: Mittermaler et al., 1997
Indonesia is home to
11% of the world's flowering plants
12% of the world's mammals
15% of all amphibians and reptiles
17% of all birds, and
37% of the world's fish.
PLANT DIVERSITY In term of plant diversity, Indonesia ranks fifth in the world
There are about 40,000 species of plant
grow in Indonesia (55% endemic)
1,845 species are inventoried
940 species are identified
There are many medicinal plants, but still
only 283 species (0.7% of species
population) are registered at BPOM
(Indonesia’s Food & Drug Administration)
as recognizable ingredients for healthcare
In Indonesia there are also many
fruits and vegetables has been used
for ancient as active ingredients of
cosmetic products
Source: Mustika Ratu ppt, 2011
PLANTS FOR HEALTH CARE (Herbal Medicine)
Temulawak (Curcuma xanthorrhiza ROXB.)
Source: from many literatures
Sambiloto (Andrographis paniculata Ness)
Pegagan (Centella asiatica)
Brotowali (Tinospora crispa L.)
Jahe (Zingiber officinale)
Laban Abang (Aglaia odorata)
Kina (Chinchona spp)
Keji Beling (Strobilanthes crispus)
Source: Medicinal Plants, Joy et al, 1998
PLANTS FOR HEALTH CARE (Herbal Medicine)
PLANTS FOR BODYCARE & COSMETIC
Aloe vera (Aloe barbadensis Milleer)
Source: from many literatures
Papaya (Carica Papaya L)
Cananga (Canangium odoratum)
Jasmine (Jasminum sambac Air)
Seaweed (Zingiber officinale)
Mangosteen (Garcinia mangostana)
Kemuning (Murraya paniculata)
Langsat (Lansium domesticum)
In recent year, there is a global interest to “back to nature” relating to safety issue.
Research on medicinal plants has attracted a lot of attention globally. A number of evidence has been demonstrate promising potential of medicinal plants used in the maintenance of personal health and well-being
WHO estimated 80% of world population uses herbal preparation and noted that 119 plants are with efficacy and used in making modern medicines
74% of those plants are used in the modern medicines the same way they use in the traditional medications
GLOBAL TREND IN THE HERBAL USE
medicinal plants will, seemingly, continue to play an important role as an health aid.
Advantages of nanotechnology:
enhance the solubility and bioavailability of active compounds
remove plant cellulose barriers, thus making the active constituents more
easily digestible, and thus, more easily assimilated into the bloodstream
enhance the pharmacological activity of active compound
easier to further dosage formulation, transport and storage
SIGNIFICANCE ROLE OF NANOTECHNOLOGY in the utilization of Indonesia Bioreseouces
Problem status in the utilization of medicinal plants:
Active compound content is very small, so it needs to large dosage form to
achieve the effective therapy
Sustainable ability of raw plant materials (large cultivation and harvesting
problems) when turn in industrialization stage
application of nanotechnology might play a significance role in
the improving the medicinal effect of natural sources
2. Global Status of Nanotechnology Development
- Learning from China and India -
Generally, there are 2 main ways of nanotech applications:
1. Particle reduction for the improvement the bioactivity and
bioavailability pharmacological effect of natural medicine is not only due to the special chemical components, but also closely connected with the physical state
2. Green synthesis (utilization of biological system to produce
nanomaterials) recently it was found that highly evolved organisms like plants, algae, diatoms, human cell and other components of eukaryotes possess the capability not only to sorb and reduce insoluble toxic metal ions, but also to convert the inorganic metal ions to metal nanoparticles
CURRENT PUBLICATIONS
Phytomedicine 15: 23–30 (2008)
Enhanced antioxidant bioactivity of Salvia miltiorrhiza (Danshen)
products prepared using nanotechnology
Liu et al, National Taiwan University, Taiwan
Goal: to compare the antioxidant activities of medicinal plant materials prepared using nanotechnology or traditional grinding methods.
Results: Stronger antioxidant bioactivities were observed for the extracts prepared using nanotechnology. It suggested that the release of the constituents will be more rapid and more complete in nanotechnology preparations compared to those prepared using the traditional methods.
Example 1.
DPPH radical scavenging activity Concentration differences of salvianolic acid
Journal of Nanobiotechnology 2007, 5:3 Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"):
a novel strategy for human cancer therapy Bisht et al, University of Delhi, India
Goal: to improve the solubilty of hydrophobic curcumin by nanoparticle-based drug delivery approaches
Results: Nanocurcumin, unlike free curcumin, is readily dispersed in aqueous media. Nanocurcumin demonstrates comparable in vitro therapeutic efficacy to free curcumin against a panel of human pancreatic cancer cell lines. Further, nanocurcumin's mechanisms of action on pancreatic cancer cells mirror that of free curcumin.
Example 2.
Solubility difference Nanocurcumin inhibits the clonogenic potential of
pancreatic cancer cell lines
Advances in Colloid and Interface Science (2011)
Green synthesis of biogenic metal nanoparticles by terrestrial and aquatic phototrophic and heterotrophic eukaryotes and biocompatible agents Narayanan et al, Pondicherry University, India
Goal: to review the recent advancements in the green synthesis of metal nanoparticles by plants, aquatic autotrophs, human cell lines, biocompatible agents and biomolecules
Highlights
► Nanoparticles synthesized using biological processes are gaining merit. ► Biological synthesis is inexpensive and uses non-hazardous chemicals. ► Use of phototrophic eukaryotes and biocompatible agents is eco-friendly. ► Greener nanoparticles are used in biomedical applications.
Example 3.
Nanoparticles: cobalt, copper, silver, gold, bimetallic
alloys, silica, palladium, platinum, iridium, magnetite
and quantum dots
3. Several Bioresources-Based
Nanotechnology R,D&C in Indonesia
Research Projects Institution
Bioprospecting Indonesian medicinal plants BPPT
(Joint research with
KRIBB Korea)
Application of nanotechnology for improving
herbal medicines efficacy in diabetes therapy
BPPT
Development of nanoparticulate herbs and their
formulation for cosmetic application (antiacne)
BPPT
(joint research with
national cosmetic industry)
Development of nanoemulsion system of herbs and
its application in healthcare application
(anticellulite)
LIPI
(joint research with
national cosmetic industry)
Development of nanoseparation system to improve
the purity of catechin from Gambier
RISTEK
(joint research with
province goverment)
Note: BPPT : Indonesia Agency for the Assessment and Application of Technology LIPI : Indonesia Institute of Sciences RISTEK: Ministry of Research and Technology, Republic of Indonesia
Ex 1: Bioprospecting Indonesian medicinal plants (Joint Research Collaboration: BPPT-Indonesia and KRIBB-Korea, Since 2009)
ACTIVITIES:
a) Collection of Indonesian plant materials
b) Extraction of the Indonesian plant materials
c) Screening of biological activities of the Indonesian plant materials:
cytotoxic, anti-inflammation, and anti-insecticidal activity
Location of
Sample Collection
Ujung Kulon
Halimun
Gunung Gede Pangrango Baluran
Meru Betiri
Pangandaran
Bodogol
Serpong (Puspiptek)
Research Members: Tarwadi, Fifit J, Doddy ISU, and Bambang S.
Sample Collected: 800 samples of plants
18
0
50
100
150
200
250
PuspiptekSerpong
GunungHalimun SalakNational Park
Ujung KulonNational Park
Gunung GedePangrango
National Park
PangandaranNatureReserve
BaluranNational Park
Meru BetiriNational Park
BodogolConservation
EducationCenter
4
125
220
54
99
125
69
106
Nu
mb
er
of
Sp
eci
men
Location
Sample Classification: based on family
19
23
5
1 4
8
25
13
7 7
1
6
2
29
2 1 3 4
1 2 3 3 1 2 1
7
3
10
2 1
10
1 1 2 3 1
5 7
2
10
5 2
49
64
6 5
1
7
1 1 1 1 2 2 1
9
16
7
2 5
1 1 4
1
25
3 1
13
26
6
1
38
1 2
6 8
17
2 2 2 1 4
7
1 3
1
16
1
8
1 1 1 1 2
7 4
52
1
18
1
11
3 1
3 3 5
1 3
12
2 5
1
9 7 10
12
17
0
10
20
30
40
50
60
70
Aca
nth
ace
ae
Am
aryl
lidac
eae
Ap
ocy
nac
eae
Ara
uca
riac
eae
Ast
erac
eae
Be
gon
iace
ae
Bo
ragi
nac
eae
Car
yop
hyl
lace
ae
Clu
siac
eae
Co
nn
arac
eae
Co
rdia
ceae
Cu
curb
itac
eae
Dill
enia
cae
Elae
oca
rpac
eae
Fab
ace
ae
Frag
ilari
acea
e
Go
od
en
iace
ae
Hip
po
crat
eace
ae
Lam
iace
ae
Lilia
ceae
Lyco
po
dia
ceae
Mal
vace
ae
Me
last
om
atac
eae
Mir
tace
ae
Mu
sace
ae
Myr
tace
ae
Ole
acea
e
Pan
dan
ace
ae
Ph
yto
lacc
ace
ae
Po
ace
ae
Po
lygo
nac
eae
Rh
izo
ph
ora
ceae
Ru
scac
eae
Sap
ind
acea
e
Sim
aru
bac
eae
Son
ner
atti
ace
ae
Teh
reac
eae
Un
ide
nti
fied
Vit
acea
e
Nu
mb
er
of
Spe
cie
s
Family
Potential USE of samples: Based on Literature Review/ Ethnopharmacology
20
FAMILY Number of
Specimen
collected
MEDICINAL USE
Fabaceae 64 Anti diabetic, Anti inflammatory, Anti cancer, Heart disease,
Rubiaceae 52 Anti diabetic, Anti inflammatory, Anti cancer, Heart disease
Euphorbiaceae 49 Anti diabetic, Anti inflammatory, Anti cancer, Heart disease
Moraceae 38 Anti diabetic, Anti inflammatory, Anti cancer, Heart disease
Asteraceae 29 Anti diabetic, Anti inflammatory, Anti cancer, Heart disease
Meliaceae 26 Anti diabetic, Anti inflammatory
Annonaceae 25 Anti inflammatory, Anti cancer
Malvaceae 25 Anti inflammatory, Anti cancer, Heart disease
Acanthaceae 23 Anti diabetic, Anti inflammatory
http://www.ars-grin.gov/duke/ethnobotuse.html
Bio Screening RESULTS
21
41 57
191
91
0
50
100
150
200
250
< 20% 20 - 50 % 50 - 100 % > 100 %
Nu
mb
er
of
Spe
cim
en
% Viability
28
68
101
49
0
20
40
60
80
100
120
< 0% 0 - 20 % 20 - 50 % 50 - 100 %
Nu
mb
er
of
Spe
cim
en
% Inhibition on NO Production
18
36
15
62
0
10
20
30
40
50
60
70
> 80 % 80 - 50 % 20 - 50 % < 20 %
Nu
mb
er
of
Spe
cim
en
Insecticidal Activity
Further Direction
Sample collection: Java Island samples from West, East Java and Banten provinces
have been collected
Outside Java samples from Kalimantan have been collected
Biological screening: other assays needed? Medical : + anti viral? , + anti diabetic?, ???
Cosmetics : whitening?, ???
Others???
Product development: what kind of products to be developed??
Anti cancer? Anti inflammation? Immune modulation? Anti diabetics? Others? refer to original location and collect more samples?
22
50 National Parks in Indonesia
www.dephut.go.id
Ex. 2: Application of nanotechnology for improving the efficacy of medicinal plants in diabetes therapy
Rationale
Rapid increasing global incidence of diabetes mellitus is becoming a serious
threat to mankind health in all parts of the world
It is the fact that diabetes can’t be cured and it has never been reported that
someone had recovered totally from diabetes.
Nowadays, there are increasing attention in the use of natural medicines for
the therapy of diabetes, since it has both effects to delay the development of
diabetic complications and correct the metabolic abnormalities.
During the past few years some of the new bioactive drugs isolated from plants
showed antidiabetic activity with more efficacy than oral hypoglycemic agents
Recent research has excitingly indicated that antihyperglycemic effects of medicinal
plants are attributed to their ability to restore the function of pancreatic tissues by
causing an increase in insulin output or inhibit the intestinal absorption of glucose
or to the facilitation of metabolites in insulin dependent processes.
WHO has pointed out this prevention of diabetes and its complications is not
only a major challenge for the future, but essential if health for all is to attain.
Year 2011 2012 2013 2014
Market
Product
Design Engineering
R&D
Resources
Funding: 100 million IDR Human: 9 persons Infrastucture: LAPTIAB Partner: -
Funding: 500 million IDR Human: 9 persons Infrastucture: LAPTIAB Partner: Klinik Herbal Hortus Medikus
Funding: 500 million IDR Human: 9 persons Infrastucture: LAPTIAB Partner: Klinik Herbal Hortus Medikus
Funding: 500 million IDR Human: 9 persons Infrastucture: LAPTIAB Partner : Klinik Herbal Hortus Medikus
TRM KEGIATAN 2011-2014
Roadmap of Nanoherbal Development for Diabetes Therapy
Nanoparticulation Technique
(bottom-up approach
Nanoparticulation Technique (top-down approach)
Characterization and Evaluation
Nanoparticle Design
Formuation Technique
(Single Dosage)
Nanoparticle Design
Internal Clinical Trial
Herbal medicine drug dosage formulation
Formulation Technique (Mixture Dosage)
Prototype I nanoparticulated
antidiabetes herbs
Drug dosage formulation in single herbs
Prototype II nanoparticulated
antidiabetes herbs
Drug dosage formulation in mixture herbs
PLANTS EXPLORED: Sambiloto (Andrographis paniculata Ness)
It is an herbaceous plant, commonly known as ‘King of Bitters”, in the family
Acanthaceae. It is widely cultivated in sourthern Asia. It has been traditionally used over
the centuries for many medicinal pusposes, particularly for diabetes therapy
A. paniculata Nano-extracts
In this study, we are trying to prepare the plant material in nanoscale system and investigate
the influence of the size on its pharmacological activity by in vitro analysis (enzyme
inhibition and insulin secretion analysis).
Size distribution analysis by PSA
Mean diameter: 150 nm
Ex. 3: Nanoencapsulation of herbal extracts and formulation in cosmetic product
(Joint Research Collaboration: BPPT and National Cosmetic Industry)
GOAL:
a) Development of method for preparing nanoherbal extracts
b) Evaluation of the improvement activity
c) Application study in cosmetic products
PLANTS EXPLORED:
1. Pegagan (Centella asiatica) herbs:
2. Mangosteen (Garcinia mangostana L.) shell:
Research Members: Eriawan R, Susi K., and Idah R.
Mangosteen
Pegagan
Cosmetic formulation Nano-extracts
Bacteria inhibition activity
Ex. 4: Nanoencapsulation of vitamin and formulation in cosmetic product
(Joint Research Collaboration: BPPT and National Cosmetic Industry)
GOAL: a) Development of method for preparing vitamin A ester with high efficacy
as antiageing agent by encapsulation in chitosan nanoparticles b) Evaluation of the improvement activity c) Application study in cosmetic products (antiageing topical cream)
BIORESOURCES EXPLORES:
Chitosan (deacetilated chitin; from shrimp shell)
Research Members: Etik M, Sjaikhurrizal EM., and Damai RS
Nanoencapsulated Vit A (size ± 130 nm)
In vitro diffusion profile (using mouse skin)
0
3
6
9
12
15
1 2 3 4 5 6 7 8 9
Waktu (jam)
% R
ele
ase
Sample 1
Sample 2
Cream formulation
Chitosan
Nanorice, nanocarbon black, nanotongkat ali, nanocurcumin, etc.
Ex. 5: Several products developed by Nanotech Indonesia
(based on industry demand)
NANOHERBAL PARTICLES FOR COSMETICS Day cream
Night crean
Soap etc
Coffee Product with Herbal Nanoparticle (Eurycoma longifolia: Tongkat Ali) for increasing stamina
Coffee Product with Herbal Nanoparticle ginger and gojiberry for increasing stamina
Technology Transfer for NanoHerbal Indonesia Collaboration with PT Gizi Indonesia, SCI-Kalbe Farma, PT
QueenBee, PT Tirta Buana Kemindo, PT Qolbi, PT Awmit, etc
http://nanoherbal-technology.com
CONCLUDING REMARKS
Indonesia has abundant bioresources that very potential to use
in healthcare and cosmetic products. Application of
nanotechnology in this field provide many benefits to improve
the quality of natural-based products.
Nowadays, particularly in Asia countries, there is research trend
in application of nanotechnology for bioresources-based
materials, in the aims of improvement of efficacy or for green
synthesis (production of nanomaterials using biological system).
In Indonesia, bioresources-based research, development, and
commercialization of nanotechnology has been started. There
are still many problems should be solved together, particulary
in term of scientific evidences and regulations.
Laboratoria for Agroindustry and Biomedical Technology Development, Indonesia Agency for the Assessment and Application of Technology (BPPT)